Moving forward with the goal of building tomorrow’s healthcare

Fusion Clinical Research works with Contract Research Organisations (CROs), Sponsors and a network of General Practitioners (GPs) to provide medical trials in a community setting.

I'm interested in...

Are you a sponsor, or contract research organisation, seeking a world-class clinical research partner for the next stage of your clinical development program? Click to learn more about the many ways Fusion Clinical Research can assist you.

Are you an expert medical professional interested in playing an active role in clinical research? Click here to learn more about the benefits to you, your patients and your community, and to register your interest.

Are you are interested in helping medical research as a volunteer? Click to learn more about the benefits of this, and to register your interest.

About

Fusion Clinical Research is owned and operated by CMAX Clinical Research, one of Australia’s oldest and most respected clinical trials units, based in Adelaide,  Australia.

For more than 25 years, CMAX Clinical Research has supported the health of local and international communities through facilitating more than 600 in-human trials resulting in hundreds of new health care products, from medicines to biotech devices.

Fusion Clinical Research works with GPs and health professionals to provide new and hard-to-access treatment options to their patients in a community setting.

Latest Trials

Influenza Vaccine Trials – Various

 Fusion Clinical Research Norwood

Fusion Clinical Trials need your help to develop new and improved vaccines for Influenza.

RSV Vaccine Trials – Various

 Fusion Clinical Research, Norwood

Fusion Clinical Trials need your help to develop new and improved vaccines for Respiratory Syncytial Virus (RSV).

F01424 – RSV mRNA Vaccine Trial

 Fusion Clinical Research, Norwood

An upcoming study to contribute to the development of a new RSV mRNA vaccine.

F01323 – COVID-19 & Flu Vaccine Trial

 Fusion Clinical Research, Norwood

This study aims to assess the efficacy of a new COVID vaccine that is to be administered in conjunction with an approved Flu vaccine.